Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell purging: an intriguing dilemma

V Rizzoli1, C Carlo-Stella

  • 1Department of Hematology, University of Parma, Italy.

Experimental Hematology
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2021
Same author

Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2021
Same author

Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2020
Same author

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Bone marrow transplantation·2017
Same author

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Bone marrow transplantation·2017
Same author

Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.

Bone marrow transplantation·2016
Same journal

Multidisciplinary Characterization of Rare MPL Y591 and R592 Variants in Myeloid Disorders: From Clinical Correlation and Literature-Based Evidence to In Silico Predictors and Structural Bioinformatics.

Experimental hematology·2026
Same journal

Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALL.

Experimental hematology·2026
Same journal

RNA Binding Protein PCBP1 Functions in the Endothelial-to-Hematopoietic Transition During Hematopoietic Stem Cell Formation.

Experimental hematology·2026
Same journal

Image-enabled cell sorting permits prospective isolation of primitive hematopoietic stem cell subsets with distinct functional potential.

Experimental hematology·2026
Same journal

Inhibition of MLLT1 Limits Growth of KMT2A::AFF1 Leukemias Without Killing Healthy Hematopoietic Stem Cells.

Experimental hematology·2026
Same journal

Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction.

Experimental hematology·2026
See all related articles

Autologous stem cell transplantation (ASCT) can lead to disease relapse due to reinfused tumor cells. This review analyzes current and emerging purging techniques to improve long-term ASCT outcomes.

Area of Science:

  • Oncology
  • Hematology
  • Transplantation Medicine

Background:

  • Autologous stem cell transplantation (ASCT) involves high-dose chemoradiotherapy followed by reinfusion of a patient's own stem cells.
  • Disease relapse is the primary factor limiting the long-term success of ASCT.
  • Evidence suggests that residual tumor cells within the autograft contribute significantly to relapse after ASCT.

Purpose of the Study:

  • To review and analyze the advantages and limitations of existing methods for purging tumor cells from autografts.
  • To discuss the potential clinical implications of novel technological approaches for improving stem cell purging.
  • To enhance the efficacy and long-term outcomes of autologous stem cell transplantation.

Main Methods:

  • Literature review of current purging techniques for autologous stem cell transplantation.

Related Experiment Videos

  • Analysis of the efficacy and limitations of established tumor cell purging methods.
  • Exploration of emerging technologies and their potential applications in stem cell purging.

    • Main Results:

    • Current purging techniques for autografts vary in effectiveness and face specific limitations.
    • The presence of reinfused tumor cells is a recognized cause of ASCT failure.
    • Newer technologies show promise for more effective purging of residual malignant cells.

    Conclusions:

    • Improving purging strategies is crucial for overcoming relapse, a major challenge in ASCT.
    • Further development and validation of advanced purging technologies are warranted.
    • Optimized purging techniques could significantly improve long-term patient outcomes following ASCT.